ConductScience.org, home

Paper32405277

Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists.

Dawoud D. Res Social Adm Pharm, 2021. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists. Papers, record 32405277. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32405277

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists.
PubMed
Journal
Res Social Adm Pharm
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
2.12
iCite
Revised in PubMed
2024-03-29
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dawoud DDalia

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
PharmacistsMajor topic
Professional RoleMajor topic
QuarantineMajor topic
Humans
Personal Protective Equipment

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132142626Mass masking in the COVID-19 epidemic: people need guidance.Lancet2020https://conductscience.org/library/papers/32142626PubMed
232273267Face masks for the public during the covid-19 crisis.BMJ2020https://conductscience.org/library/papers/32273267PubMed
332325027Universal weekly testing as the UK COVID-19 lockdown exit strategy.Lancet2020https://conductscience.org/library/papers/32325027PubMed
432267544Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/32267544PubMed
532378252A phased approach to unlocking during the COVID-19 pandemic-Lessons from trend analysis.Int J Clin Pract2020https://conductscience.org/library/papers/32378252PubMed
632360552COVID-19-We urgently need to start developing an exit strategy.Int J Infect Dis2020https://conductscience.org/library/papers/32360552PubMed
732217609Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.mBio2020https://conductscience.org/library/papers/32217609PubMed
832380041COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges.Lancet2020https://conductscience.org/library/papers/32380041PubMed
932113704The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.J Autoimmun2020https://conductscience.org/library/papers/32113704PubMed
1028426646Community Mitigation Guidelines to Prevent Pandemic Influenza - United States, 2017.MMWR Recomm Rep2017https://conductscience.org/library/papers/28426646PubMed
1132231320Blocking information on COVID-19 can fuel the spread of misinformation.Nature2020https://conductscience.org/library/papers/32231320PubMed
1232238336Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action.JMIR Public Health Surveill2020https://conductscience.org/library/papers/32238336PubMed
1332273278Covid-19: should the public wear face masks?BMJ2020https://conductscience.org/library/papers/32273278PubMed
1432387229Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures?Res Social Adm Pharm2021https://conductscience.org/library/papers/32387229PubMed
1532124000Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong.Graefes Arch Clin Exp Ophthalmol2020https://conductscience.org/library/papers/32124000PubMed
1632350462Antibody responses to SARS-CoV-2 in patients with COVID-19.Nat Med2020https://conductscience.org/library/papers/32350462PubMed
1732240973Peer-to-Peer Contact Tracing: Development of a Privacy-Preserving Smartphone App.JMIR Mhealth Uhealth2020https://conductscience.org/library/papers/32240973PubMed
1832387230When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19.Res Social Adm Pharm2021https://conductscience.org/library/papers/32387230PubMed
1932238757Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).J Microbiol Biotechnol2020https://conductscience.org/library/papers/32238757PubMed
2032423584Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.Lancet2020https://conductscience.org/library/papers/32423584PubMed

See all 36 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
39928066Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour.Int J Clin Pharm2025https://conductscience.org/library/papers/39928066PubMed
39045311Optimal approaches for COVID-19 control: the use of vaccines and lockdowns across societal groups.Front Epidemiol2024https://conductscience.org/library/papers/39045311PubMed
38021255Experience and Learning from the COVID-19 Pandemic in Portugal: Perceptions of Community Pharmacy Professionals.Port J Public Health2023https://conductscience.org/library/papers/38021255PubMed
36923065Experiences and learnings of pharmacists, students, and clinical assistants working collaboratively in a COVID-19 vaccination clinic: a qualitative study.Explor Res Clin Soc Pharm2023https://conductscience.org/library/papers/36923065PubMed
36353006Knowledge of the primary healthcare physicians in the Al-Baha Region about COVID-19 personal protective measures.J Family Med Prim Care2022https://conductscience.org/library/papers/36353006PubMed
35388102SaliVISION: a rapid saliva-based COVID-19 screening and diagnostic test with high sensitivity and specificity.Sci Rep2022https://conductscience.org/library/papers/35388102PubMed
35279102Exit strategies from lockdowns due to COVID-19: a scoping review.BMC Public Health2022https://conductscience.org/library/papers/35279102PubMed
35120863Expanded roles of community pharmacists in COVID-19: A scoping literature review.J Am Pharm Assoc (2003)2022https://conductscience.org/library/papers/35120863PubMed
35015167COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach.Eur J Health Econ2022https://conductscience.org/library/papers/35015167PubMed
34924315Pharmacy interventions on COVID-19 in Europe: Mapping current practices and a scoping review.Res Social Adm Pharm2022https://conductscience.org/library/papers/34924315PubMed
34135054Rapid realist review of the role of community pharmacy in the public health response to COVID-19.BMJ Open2021https://conductscience.org/library/papers/34135054PubMed
34043172Predicting COVID-19 cases using bidirectional LSTM on multivariate time series.Environ Sci Pollut Res Int2021https://conductscience.org/library/papers/34043172PubMed
33729527The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis.Int J Pharm Pract2021https://conductscience.org/library/papers/33729527PubMed
33588970Knowledge, Attitude, and Practices (KAPs) of Community Pharmacists Regarding COVID-19: A Cross-Sectional Survey in 2 Provinces of Pakistan.Disaster Med Public Health Prep2022https://conductscience.org/library/papers/33588970PubMed
33564239Healthcare Workers' Knowledge, Attitude, and Practice Regarding Personal Protective Equipment for the Prevention of COVID-19.J Multidiscip Healthc2021https://conductscience.org/library/papers/33564239PubMed
33364224Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.Front Public Health2020https://conductscience.org/library/papers/33364224PubMed
32912829Pharmacy practice research priorities during the COVID-19 pandemic: Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group.Res Social Adm Pharm2021https://conductscience.org/library/papers/32912829PubMed
32792322Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic.Res Social Adm Pharm2021https://conductscience.org/library/papers/32792322PubMed
32784696The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist.Pharmacy (Basel)2020https://conductscience.org/library/papers/32784696PubMed
32507575Caring for patients with diabetes during COVID-19 pandemic: Important considerations for pharmacists.Res Social Adm Pharm2021https://conductscience.org/library/papers/32507575PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32405277

GET https://conductscience.org/api/papers/v1/32405277/references?page=2